Viewing Study NCT00601718

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-07-13 @ 7:44 PM
Study NCT ID: NCT00601718
Status: COMPLETED
Last Update Posted: 2017-05-25
First Post: 2008-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Sponsor: University of Washington
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Nasal Type Extranodal NK/T-cell Lymphoma View
None Anaplastic Large Cell Lymphoma View
None Angioimmunoblastic T-cell Lymphoma View
None Contiguous Stage II Mantle Cell Lymphoma View
None Cutaneous B-cell Non-Hodgkin Lymphoma View
None Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue View
None Nodal Marginal Zone B-cell Lymphoma View
None Noncontiguous Stage II Mantle Cell Lymphoma View
None Recurrent Adult Burkitt Lymphoma View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Adult Diffuse Mixed Cell Lymphoma View
None Recurrent Adult Diffuse Small Cleaved Cell Lymphoma View
None Recurrent Adult Grade III Lymphomatoid Granulomatosis View
None Recurrent Adult Hodgkin Lymphoma View
None Recurrent Adult Immunoblastic Large Cell Lymphoma View
None Recurrent Adult Lymphoblastic Lymphoma View
None Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma View
None Recurrent Grade 1 Follicular Lymphoma View
None Recurrent Grade 2 Follicular Lymphoma View
None Recurrent Grade 3 Follicular Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Recurrent Marginal Zone Lymphoma View
None Recurrent Mycosis Fungoides/Sezary Syndrome View
None Recurrent Small Lymphocytic Lymphoma View
None Splenic Marginal Zone Lymphoma View
None Stage I Cutaneous T-cell Non-Hodgkin Lymphoma View
None Stage I Mantle Cell Lymphoma View
None Stage I Mycosis Fungoides/Sezary Syndrome View
None Stage II Cutaneous T-cell Non-Hodgkin Lymphoma View
None Stage II Mycosis Fungoides/Sezary Syndrome View
None Stage III Cutaneous T-cell Non-Hodgkin Lymphoma View
None Stage III Mantle Cell Lymphoma View
None Stage III Mycosis Fungoides/Sezary Syndrome View
None Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma View
None Stage IV Mantle Cell Lymphoma View
None Stage IV Mycosis Fungoides/Sezary Syndrome View
None Waldenström Macroglobulinemia View
Keywords: